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Abstract
Background: Patients who undergo psychological treatment can report both negative and positive effects, but
evidence of factors influencing the likelihood of negative effects is limited.
Aims: To identify aspects of the organisation and delivery of secondary care psychological treatment services that
are associated with patient experiences of negative effects.
Method: Cross-sectional survey of people with anxiety and depression who ended psychological treatment delivered
by 50 NHS trusts in England. Respondents were asked about how their treatment was organised and delivered and
whether they experienced lasting negative effects.
Results: Of 662 respondents, 90 (14.1%) reported experiencing lasting negative effects. People over the age of 65 were
less likely than younger respondents to report negative effects. There was an association between reporting neutral or
negative effects and not being referred at what respondents considered to be the right time (OR = 1.712, 95% CI =
1.078–2.726), not receiving the right number of sessions (OR = 3.105, 95% CI = 1.934–4.987), and not discussing
progress with their therapist (OR 2.063, 95% CI = 1.290–3.301).
Conclusions: One in seven patients who took part in this survey reported lasting negative effects from psychological
treatment. Steps should be taken to prepare people for the potential for negative experiences of treatment, and
progress reviewed during therapy in an effort to identify and prevent negative effects.
Introduction
One in six adults experience a common mental health
problem such as anxiety and depression [1]. People with
anxiety and depression experience emotional distress, re-
duced quality of life [2], and impaired social functioning
[3]. The National Institute for Health and Clinical
Excellence in England recommend psychological interven-
tions as first line treatments for anxiety and depression [4,
5]. In England, most people who undergo psychological
treatment for anxiety and depression receive it in primary
care. However, patients with more severe conditions,
those with complex difficulties associated with coexisting
conditions, and people judged at high risk of suicide are
treated by specialist teams based in secondary care mental
health services.
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Although psychological interventions for depression
and anxiety generally have positive effects [6, 7], less
consideration has been given to their potential for nega-
tive ones [8, 9]. Outcome measures are often used to
monitor for adverse effects of treatment [10], however
the results of these measures do not take into account
patients’ subjective experiences of therapy. Lasting nega-
tive effects may include a worsening of symptoms, or the
development of new ones, such as anger, loss of self-
esteem and anxiety following treatment [11].
Secondary analysis of data from a national survey of
14,587 patients receiving treatment in England found that
5% of patients reported lasting negative effects from the
psychological treatment they had received [11]. With a
high potential for lasting negative effects, it is important
to examine their aetiology in order to prevent them [12].
The likelihood of negative effects may be greater
among people with personality disorder and people who
have had childhood trauma, which are commonly seen
in secondary care and frequently associated with adverse
events of therapy [13–16]. Other patient factors which
are associated with negative effects include unemploy-
ment, disability, and expectations of treatment benefits
[17]. Age, ethnicity, and sexuality are also associated
with the likelihood of patient-reported negative effects:
those over 65 years are less likely than younger patients
to report negative outcomes but people from sexual and
ethnic minorities are more likely to report such concerns
[11]. Negative effects may also be more common among
patients who are less optimistic about their treatment
[18] and among those who do not feel they receive
enough information about their treatment before it be-
gins [11]. If people have preferences about their treat-
ment, which are not met, they are more likely to report
a poor outcome of therapy [19]. Although patient demo-
graphic and clinical factors appear to influence the likeli-
hood of negative experience of psychological treatment,
less is known about the relationship between the process
of delivering psychological treatment and reports of
negative outcomes.
Service structures, policies, and constraints may influ-
ence whether patients experience negative effects of their
treatment. A thematic analysis of factors which lead to pa-
tient reported negative experiences included experiences
not matching expectations, and services providing little or
no information about what the service offered [20]. Data
from the Improving Access to Psychological Treatment
(IAPT) programme, show that better clinical outcomes
were achieved by services that offered more treatment ses-
sions to patients, and by services that followed NICE treat-
ment recommendations more closely [21]. Delay in
referral to appropriate psychological services may also
have a negative impact on psychotherapy outcomes [22].
However, gaps remain in our understanding of the
contribution that the process of delivering psychological
treatment has on the likelihood of patients experiencing
negative effects.
We therefore undertook a secondary analysis of data
from a survey of 662 patients conducted as part of the
National Clinical Audit of Anxiety and Depression [23].
The survey was run by the Royal College of Psychiatrists
(RCPsych) in collaboration with the British Psychological
Society (BPS). The audit involved an examination of
process and outcomes of care using data from case-
notes, a survey of therapists and a patient survey. The
main analysis for this report uses data from the patient
survey. The aim of the analysis was to identify aspects of
the organisation and delivery of secondary care psycho-
logical therapy services that are associated with reported
negative effects. We aimed to build on our previous
study by investigating the prevalence of negative effects
among people treated by secondary care services rather
than those treated predominately by IAPT, in a sample
of patients who had completed their treatment. We also
wanted to examine the effects of new predictor variables,
including whether patients had had discussions previous
experience of therapy with their therapist and whether
they discussed their progress during their therapy
sessions.
Method
All 54 providers of NHS secondary care mental health
services (known as ‘Trusts’) in England were invited to
take part in the case-note audit, and 50 (92.6%) submit-
ted data. Each Trust was asked to register all teams that
deliver psychological treatment to adults (aged 18 or
over) with anxiety and depression, including both in-
patient and community services.
All psychological therapy teams were asked to compile
a list of all patients who ended psychological therapy be-
tween 1st September 2017 and 31st August 2018. This
included people who completed their treatment, as well
as those who did not complete or dropped out of treat-
ment. The audit team at the Royal College of Psychia-
trists then randomly selected 30 patients from each team
who were sent a copy of the survey. Any patients with a
coexisting diagnosis of a psychotic condition were ex-
cluded from the survey. If fewer than 30 patients had
completed treatment during this 12-month period, all
eligible patients were sent a copy of the survey.
The National Research Ethics Service and the Ethics
and Confidentiality Committee of the National Informa-
tion Governance Board advised that formal ethical ap-
proval was not required because this was an audit and
patient identifiable data were not collected. All proce-
dures contributing to this work comply with the ethical
standards of the relevant national and institutional com-
mittees on human experimentation and with the
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Helsinki Declaration of 1975, as revised in 2008. Ap-
proval for the secondary analysis of the data in this study
was obtained from the Healthcare Quality Improvement
Partnership prior to the start of data analysis.
One of the questions in the audit asked service users
to indicate whether they agreed or disagreed with the
statement: “I have experienced lasting bad effects from
the treatment”, to which they could respond “strongly
agree”, “slightly agree”, “neutral”, “slightly disagree” or
“strongly disagree”.
Potential predictor variables were chosen following a re-
view of previous literature and discussion with a service
user advisor to the project (P.S.): they included demo-
graphic factors (age, gender, ethnicity), along with the fol-
lowing aspects of the organisation and delivery of care
where patients could respond “strongly agree”, “slightly
agree”, “neutral”, “slightly disagree” or strongly disagree”:
– I was referred to therapy at the right time
– The waiting time for my treatment to start was
reasonable
– I received enough information about my therapy
before it began
– I received the right number of therapy sessions from
this service
– My therapist and I agreed goal(s) for my therapy
– I had a discussion with my therapist about my
previous therapy and experiences
– I had a discussion with my therapist about my
overall care (e.g., medication, appointments with
your care coordinator)
– Did you and your therapist discuss progress during
your therapy?
Analysis
The primary outcome for this study was a service user re-
port of ‘lasting bad effects from treatment’. A preliminary
analysis of data using crosstabulation indicated that the
demographic characteristics (age, gender, ethnicity) of ser-
vice users who stated that they were ‘neutral’ about
whether they had experienced a lasting bad effect from
their treatment were more closely aligned to those report-
ing negative effects than positive effects, we therefore in-
cluded the responses of those who were neutral about
having experienced lasting bad effects with those who re-
ported that they had such experiences. We used the same
approach to convert other items to dichotomous variables
prior to the main analysis. A univariate analysis was
undertaken to explore associations between the primary
outcome and demographic factors (age, gender, ethnicity),
and predictor variables on the process of care.
We examined whether there was clustering between
variables at the level of service but found no evidence of
clustering (p = 0.146, 95% CI = 0.051–0.753). We
generated a multivariate model of factors which pre-
dicted the likelihood of negative effects using binary lo-
gistic regression. We used backwards elimination to
delete any variables from the model whose removal did
not result in any statistically significant loss of fit. We
also used data from the case-note audit to explore the
representativeness of those who completed the survey
compared to those who did not. Analysis was completed
using the statistical package IBM SPSS (version 26).
Results
Surveys were sent to 4462 service users treated by 232
psychological therapy services across the country: 662
surveys (14.8, 95% CI 13.82–15.92) were completed and
included in this analysis.
The characteristics of the service-users who completed
the survey are presented in Table 1 along with the ag-
gregate data from the case-note audit. Survey respon-
dents were more likely to be female, older and white
compared with non-respondents. Overall, 14.1% (n = 90)
of respondents reported experiencing lasting bad effects,
of those 6.1% (n = 39) strongly agreed and 8% (n = 51)
slightly agreed, 13.7% (n = 87) were neutral, and 72.2%
(n = 459) indicated that they had not experienced lasting
bad effects, with 7.7% (n = 49) who slightly disagreed
and 64.5% (n = 410) strongly disagreed. When ‘agree’
and ‘neutral’ categories were combined into dichotom-
ous variable, the total was 27.8% (n = 177). Univariate as-
sociations between the experience of lasting bad effects
and predictor variables are presented in Table 2.
The results of the multivariate analysis are presented
in Table 3, which contains all the covariates that
remained in the model after backwards regression. The
likelihood of reporting neutral or lasting negative effects
was greater among service users who felt they were not
referred for therapy at right time, those who felt they did
not receive the right number of sessions, and those who
reported that they did not discuss their progress with
their therapist.
Discussion
Analysis of data from 662 people who received psycho-
logical therapy for anxiety and depression in secondary
care mental health services in England found that 14.1%
reported a lasting negative effect as a result of their
treatment, and 13.7% reported being ‘neutral’ about
whether they had a negative effect. This is a higher pro-
portion than the 5.2% of patients who reported negative
effects in a previous investigation [11]. This is potentially
due to the sample being derived exclusively from sec-
ondary care mental health services where the patients
have more severe or complex difficulties. Patients over
the age of 65 were less likely to report negative effects
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compared to younger people. This is consistent with
previous findings [11].
The term ‘lasting’ was included in the patient survey
following initial qualitative interviews prior to a previous
round of this study, where it was acknowledged that pa-
tients may feel uneasy or unsettled during therapy, but
that these difficult feelings were worked through during
therapy. The term lasting was included as this implied
that the negative effects last beyond the treatment. It is
possible that this term is subjective and should be con-
sidered in any future investigation.
We found associations between the likelihood of ex-
periencing neutral or lasting bad effects and three com-
ponents of the organisation and delivery of services.
First, there was an association between not being re-
ferred ‘at the right time’ for therapy and neutral or last-
ing bad effects. In a thematic analysis of 447 of the
service-user surveys [24] this was identified as a major
concern. Service users felt that therapy was not easily ac-
cessible and were concerned with difficulties meeting
the threshold for services, with people being assessed as
‘too well’ to be referred for treatment. Our findings pro-
vide further evidence of the need to ensure that people
with common mental health conditions have timely ac-
cess to psychological treatment.
Not receiving ‘the right number’ of therapy sessions
was also associated with experiencing neutral or lasting
negative effects of treatment, mirroring the thematic
analysis report which identified that the number of ses-
sions received was often not enough to meet the service-
user’s needs [24]. This is consistent with IAPT findings
that services which offer a greater number of sessions to
service-users have a more positive impact on recovery
[21].
Not discussing progress with therapist showed the
strongest relationship to likelihood of reporting neutral
or lasting negative effects. This is of particular concern
given previous reports that patients rarely disclose nega-
tive reactions to their therapists or services [20, 25].
In-session monitoring has been found to improve pa-
tient outcomes [26–28]. Discussions regarding patient
progress may help maintain a therapeutic relationship,
allow for collaboration, and modification of specific strat-
egies for treatment [29]. A lack of discussion on progress
may make it difficult for patients to engage in therapy
[20]. Therapists may also have a differing view on patient
progress [30]. These discussions may highlight patient’s
experiences of therapy, identifying concerns patient may
have and increasing the opportunities to avert negative
outcomes. Despite the evidence that progress monitoring
can be effective in improving treatment outcome, it re-
mains an infrequent practice [31, 32].
There are a number of strengths of the present study.
The data come from a large number of services across
England. This study was closely based on a previous ana-
lysis of negative outcomes delivered mainly to patients
in primary care [11]. However, unlike the previous study,
all those who took part in this new study had completed
their therapy when they completed the survey. Some pa-
tients have both positive and negative experiences dur-
ing therapy, and working through difficult experiences
can be part of the therapeutic process [33] Further in-
vestigation is required as to whether those who report
lasting harm from their therapy also found it helpful.
Table 1 Demographic characteristics of study participants
Demographic Characteristics Study sample, n (%) Sample included in the case-note audit Difference in proportions (95% CI)
Age, years 624 4462
18–25 38 (6.1) 680 (15.2) −9.15 (−6.67 to − 11.16)
26–35 75 (12) 923 (20.7) −8.67 (− 5.56 to − 11.36)
36–45 94 (15.1) 808 (18.1) −3.04 (− 0.25 to − 5.96)
46–55 135 (21.6) 811 (18.2) 3.46 (0.12 to 7.12)
56–65 88 (14.1) 436 (9.8) 4.33 (1.59 to 7.48)
> 65 194 (31.1) 804 (18) 13.07 (9.3 to 17.05)
Gender 626 4459
Male 208 (33) 1484 (33.3) −0.21 (−3.88 to 4.12)
Female 418 (66.5) 2966 (66.5) 0.06 (−3.86 to 4.16)
Ethnicity 625 4202
White 557 (89.1) 3691 (87.8) 1.28 (−1.65 to 3.78)
Mixed / Multiple 14 (2.2) 141 (3.35) −1.12 (−0.55 to − 2.25)
Asian 29 (4.6) 181 (4.3) 0.33 (−1.27 to 2.45)
Black 17 (2.7) 94 (2.2) 0.48 (−0.71 to 2.22)
Other 8 (1.3) 95 (2.3) −0.98 (− 0.41 to − 1.83)
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Our survey questions were developed through in-depth in-
terviews with patients and a person with lived experience of
anxiety and depression helped to select items for inclusion in
this analysis. While previous studies have examined patient
factors and environmental factors that may increase the like-
lihood of negative effects of psychological treatments [17] we
focussed on aspects of the organisation and delivery of ser-
vices because these may be amenable to change.
Table 2 Univariate analysis of neutral or lasting bad effects – demographic factors and process of care
Neutral or lasting negative effects, n/N (%) OR (95% CI)
Age, years
> 65 29/181 (16) 1
18–25 12/38 (31.6) 2.419 (1.097–5.335)
26–35 24/72 (33.3) 2.621 (1.395–4.924)
36–45 23/91 (25.3) 1.773 (0.956–3.287)
46–55 49/133 (36.8) 3.057 (1.798–5.119)
56–65 25/85 (29.4) 2.184 (1.183–4.030)
Gender
Female 112/404 (27.7) 1
Male 48/198 (24.2) 0.834 (0.564–1.234)
Ethnicity
White 138/535 (25.8) 1
Mixed 2/14 (14.3) 0.479 (0.106–2.169)
Asian 8/28 (28.6) 1.151 (0.496–2.672)
Black 5/16 (31.3) 1.308 (0.446–3.830)
Other 4/8 (50) 2.877 (0.710–11.659)
I was referred to therapy at the right time
Agree 76/412 (18.4) 1
Neutral/Disagree 97/205 (47.3) 3.971 (2.742–5.751)
The waiting time for my treatment to start was reasonable
Agree 67/357 (18.8) 1
Neutral/Disagree 101/250 (40.4) 2.934 (2.034–4.233)
I received enough information about my therapy before it began
Agree 71/382 (18.6) 1
Neutral/Disagree 99/226 (43.8) 3.415 (2.363–4.934)
I received the right number of therapy sessions from this service
Agree 64/377 (17) 1
Neutral/Disagree 113/252 (44.8) 3.976 (2.757–5.733)
My therapist and I agreed goals for my therapy
Agree 103/478 (21.5) 1
Neutral/Disagree 73/147 (49.7) 3.592 (2.432–5.405)
I had a discussion with my therapist about my previous therapy and experiences
Agree 116/462 (25.1) 1
Neutral/Disagree 60/162 (37) 1.755 (1.198–2.571)
I had a discussion with my therapist about my overall care
Agree 90/423 (21.3) 1
Neutral/Disagree 84/199 (42.2) 2.703 (1.876–3.894)
Did you and your therapist discuss your progress?
Yes 98/462 (21.2) 1
No/Unsure 79/166 (47.6) 3.373 (2.312–4.920)
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Some important limitations must also be considered.
The data are limited to service-user experiences in sec-
ondary care services. The response rate was low with
662 (14.8%) taking part out of the 4462 who were sent a
copy: when compared to the data from the case-note
audit, it was more likely for non-respondents to be
younger, male, and from minority ethnic groups. We do
not know if the proportion of those experiencing neutral
or lasting bad effects of treatment would be the same
among those who did not respond. It is also possible
that responses to the survey questions may differ de-
pending on whether the respondent was a completer or
non-completer of therapy, however this information was
not collected as part of the audit and so we were unable
to include in our analysis. It would be useful for this to
be considered for future studies. As neutral and agree
categories were combined in order to calculate dichot-
omous variables, it is possible that some respondents
were included who did not experience lasting adverse ef-
fects. This should be considered in future studies. The
study design is reliant upon retrospective views of indi-
vidual experiences rather than prospectively gathered
routine service data. The cross-sectional design of the
study means that we are not able to conclude that the
associations we found are causal. It is possible that recall
bias led people who may have negative experiences of
therapy to indicate problems with when and how their
therapy was delivered. Future prospective studies could
reduce the potential for this bias by examining the
process of care during therapy and subsequently asses-
sing patient experiences of the outcome of their
treatment.
Important factors that should be considered in future
studies include clinician characteristics and the interac-
tions between clinician and patient. It is not clear from
this study the contribution these interactions may have
upon a patient’s likelihood of reporting lasting negative
effects from their treatment.
Our findings suggest that a significant proportion of
service-users with anxiety and depression may report
lasting negative effects of psychological treatment in sec-
ondary care: some people do not feel helped, but instead
feel harmed. Services should inform service users prior
to starting treatment that although most people who
complete psychological treatment feel benefits, negative
experiences are not infrequent [34]. Clinicians delivering
psychological therapy in secondary care settings should
ensure that they discuss progress with patients, and fur-
ther efforts are needed to reduce waiting times and pro-
vide sufficient sessions for service-user’s needs to be
addressed. Future research should aim to develop a bet-
ter understanding the content of these lasting negative
effects and how they affect clients to reduce and mitigate
the risks. Longitudinal studies are needed to develop a
better understanding of the relationship between the
process and outcomes of psychological therapies. Experi-
mental studies are needed to see if changing the way
that therapy is delivered can help reduce the incidence
of patient reported negative outcomes.
Conclusion
One in seven patients receiving psychological therapy in
secondary care mental health services for anxiety and
depression reported experiencing lasting bad effects
from their treatment. Being referred at the right time,
receiving the right number of sessions, and discussing
progress with the therapist may help reduce the likeli-
hood of this adverse outcome.
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